Partnering with the National Center for the Middle Market (NCMM), we surveyed 1,000 executives from middle market companies. Our spearheading research helps middle market business owners take advantage of forecasted business trends and be prepared for emerging risks.
What we learned from the latest release
According to the year-end survey, middle market companies reported double digit revenue growth last year, but look to 2024 with cautious optimism. Inflation, recession and talent shortage/employee retention were seen as top emerging risks.
- 8.1% mean revenue growth expected in the next year
- 73% expressed confidence in the U.S. economy
- 72% will consider increasing insurance coverage due to inflation
Findings from Industry Spotlight Reports
Manufacturing
Coming off of another strong performance in 2023, middle market manufacturers have a cautiously optimistic outlook. Supply chain issues are more of a challenge for middle market manufacturers. More than a third of these companies have been directly impacted by recent disruptions or constraints in their supply chains, significantly higher than other industries.
Technology
Growth was mixed for middle market technology companies. With innovation in the DNA of this sector, more than two in five of these companies are actively testing or already using AI, significantly higher than the overall middle market, and their primary uses include working with data and improving efficiencies. Additionally, two in five middle market technology companies noted that they had experienced a cyber or data disruption in the past two years.
Financial Services
Strong performance continues for middle market financial services companies. Revenue growth for these companies was well ahead of the middle market overall, and employment growth was even better. Inflation has been a lingering concern for these companies, and the costs that have challenged them most – marketing, wages, and services – are showing little sign of abating anytime soon.
Life Sciences
Performance ramped lower for middle market life sciences companies in 2023, after a pandemic-fueled surge. Three in five middle market life sciences companies, particularly biotechnology companies, are actively testing or already using AI, and their most common uses include customer service and analyzing data. Changes in leadership or control, such as from CEO successions or mergers and acquisitions activity, led the emerging risks for this sector.
Insights and expertise
This document is advisory in nature and is offered as a resource to be used together with your professional insurance advisors in maintaining a loss prevention program. It is an overview only, and is not intended as a substitute for consultation with your insurance broker, or for legal, engineering or other professional advice.
Chubb is the marketing name used to refer to subsidiaries of Chubb Limited providing insurance and related services. For a list of these subsidiaries, please visit our website at www.chubb.com. Insurance provided by ACE American Insurance Company and its U.S. based Chubb underwriting company affiliates. All products may not be available in all states. This communication contains product summaries only. Coverage is subject to the language of the policies as actually issued. Surplus lines insurance sold only through licensed surplus lines producers. Chubb, 202 Hall's Mill Road, Whitehouse Station, NJ 08889-1600.